Who are Enduron's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Quimethazin, Saluron, Corzide, Diuril, olmesartan medoxomil-hydrochlorothiazide, Benicar.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/methylclothiazide.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

Enduron — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enduron (methylclothiazide) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Thiazide Diuretic. Area: Cardiovascular.

marketed Thiazide Diuretic Solute carrier family 12 member 3 Cardiovascular Live · refreshed every 30 min

Target snapshot

Enduron (methylclothiazide).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Enduron TARGET	methylclothiazide		marketed	Thiazide Diuretic	Solute carrier family 12 member 3	1960-01-01
Quimethazin	QUINETHAZONE		marketed	quinethazone	Solute carrier family 12 member 3	1963-01-01
Saluron	HYDROFLUMETHIAZIDE	Shire Llc	marketed	Thiazide Diuretic	Solute carrier family 12 member 3	1959-01-01
Corzide	BENDROFLUMETHIAZIDE		marketed	Thiazide Diuretic	Solute carrier family 12 member 3	1959-01-01
Diuril	CHLOROTHIAZIDE	Salix Pharms	marketed	Thiazide Diuretic	Solute carrier family 12 member 3	1958-01-01
olmesartan medoxomil-hydrochlorothiazide	OLMESARTAN	Cosette	marketed	Thiazide Diuretic [EPC]		2019-01-01
Benicar	OLMESARTAN MEDOXOMIL	Cosette	marketed	Thiazide Diuretic [EPC]	Type-1 angiotensin II receptor	2002-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Thiazide Diuretic class)

· 2 drugs in this class
Salix Pharms · 1 drug in this class
Shire Llc · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Enduron — Competitive Intelligence Brief. https://druglandscape.com/ci/methylclothiazide. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing